| Literature DB >> 28741568 |
Matteo Cereda1, Thanos P Mourikis1, Francesca D Ciccarelli2.
Abstract
Cancer genomes acquire somatic alterations that largely differ between and within cancer types. Several of these alterations inactivate genes that are normally functional with no deleterious consequences on cancer cells due to genetic redundancy. Here we discuss how this leads to cancer synthetic dependencies that can be exploited in therapy.Entities:
Keywords: cancer genomics; functional redundancy; paralog dependency; personalized medicine; synthetic lethality
Mesh:
Year: 2016 PMID: 28741568 DOI: 10.1016/j.trecan.2016.03.003
Source DB: PubMed Journal: Trends Cancer ISSN: 2405-8025